GMP Recombinant Proteins and Synthetic Peptides
| Products | Origin | Description | Price/CofA |
|---|---|---|---|
| HIV-1 p65 | Clade B | Recombinant HIV-1 Reverse Transcriptase protein produced in E. coli Expression System. | Details HIV-1 p65 CofA |
| HIV-1 gp160 | Clade C | Recombinant HIV-1 gp160 derived from HIV-1 clade C and expressed in HEK-293. | Details HIV-1 gp160 CofA |
| HIV-1 gp41 | Clade B fused with immunodominant domains of Clades A, C, D and E | Recombinant HIV-1 gp41 containing immunodominant epitopes from clades A, B, C, D, and E and produced in E.coli Expression System. | Details HIV-1 gp41 CofA |
| HIV-1 group O specific peptide | Peptide Synthesis | Peptide representing immunodominant epitope of HIV-1 group O envelope protein gp41. | Details HIV-1 Grp O CofA |
| HIV-1 p24 | Clade B | Recombinant HIV-1 p24 protein produced in E.coli Expression System. | Details HIV-1 p24 CofA |
| HIV-2 p27 | Full length protein | Recombinant protein produced in E. coli. | Details HIV-2 p27 CofA |
| HIV-2 specific peptide (G-5) | Peptide Synthesis | Peptide representing immunodominant epitope of HIV-2 gp36 envelope protein. | Details HIV-2 G5 CofA |
| HIV-2 specific peptide (G-5) - BSA | Peptide Synthesis | 12 amino acid synthetic peptide conjugated to BSA. | Details HIV-2 G5-BSA CofA |